Literature DB >> 19870634

THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION.

M Theiler1, H H Smith.   

Abstract

The response of rhesus monkeys to a subcutaneous inoculation with varying amounts of virus modified by prolonged cultivation in vitro has been studied. The tissue components of the medium consisted of chick embryo tissue containing minimal amounts of nervous tissue. The immunity produced in monkeys, as measured by the antibody titer developed, has no relation to the amount of virus inoculated. Monkeys inoculated subcutaneously with the tissue culture virus are rendered immune to a subsequent injection of a highly virulent yellow fever virus. This resistance is already present 7 days after vaccination. The subcutaneous inoculation of the culture virus into immune persons leads to a substantial increase of the serum antibody titer. The results of vaccinating eight normal persons with culture virus are presented. The reactions were minimal. The highest temperature recorded following vaccination was 37.4 degrees C. The sera taken from the eight vaccinated persons 2 to 4 weeks after inoculation with the tissue culture virus showed the presence of yellow fever antibodies.

Entities:  

Year:  1937        PMID: 19870634      PMCID: PMC2133527          DOI: 10.1084/jem.65.6.787

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  The Behavior of the Virus of Yellow Fever in Monkeys and Mice.

Authors:  A W Sellards
Journal:  Proc Natl Acad Sci U S A       Date:  1931-06       Impact factor: 11.205

2.  THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS.

Authors:  M Theiler; H H Smith
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

3.  VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

Authors:  W A Sawyer; S F Kitchen; W Lloyd
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

  3 in total
  116 in total

1.  Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.

Authors:  R G van Der Most; K Murali-Krishna; R Ahmed; J H Strauss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Molecular strategies for interrupting arthropod-borne virus transmission by mosquitoes.

Authors:  C D Blair; Z N Adelman; K E Olson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.

Authors:  B K Sil; L M Dunster; T N Ledger; M R Wills; P D Minor; A D Barrett
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Observations on homologous serum jaundice and the usefulness of plasma.

Authors:  J G ALLEN
Journal:  J Natl Med Assoc       Date:  1958-07       Impact factor: 1.798

Review 5.  The development of vaccines: how the past led to the future.

Authors:  Stanley A Plotkin; Susan L Plotkin
Journal:  Nat Rev Microbiol       Date:  2011-10-03       Impact factor: 60.633

6.  Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

Authors:  M A Martins; M L Silva; A P V Marciano; V Peruhype-Magalhães; S M Eloi-Santos; j G L Ribeiro; R Correa-Oliveira; A Homma; E G Kroon; A Teixeira-Carvalho; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  Rules to 'prime' by.

Authors:  Paul G Thomas; Peter C Doherty
Journal:  Nat Immunol       Date:  2009-01       Impact factor: 25.606

8.  Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.

Authors:  Szymon Pach; Tim M Sarter; Rafe Yousef; David Schaller; Silke Bergemann; Christoph Arkona; Jörg Rademann; Christoph Nitsche; Gerhard Wolber
Journal:  ACS Med Chem Lett       Date:  2020-03-03       Impact factor: 4.345

9.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 10.  Vaccines for Venezuelan equine encephalitis.

Authors:  Slobodan Paessler; Scott C Weaver
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.